[HTML][HTML] Biomarkers for Kawasaki disease: clinical utility and the challenges ahead

H Chaudhary, J Nameirakpam, R Kumrah…�- Frontiers in�…, 2019 - frontiersin.org
Kawasaki disease (KD) has replaced acute rheumatic fever as the most common cause
of acquired heart disease in children in the developed world and is increasingly being …

The clinical utility and safety of a new strategy for the treatment of refractory Kawasaki disease

T Ebato, S Ogata, Y Ogihara, M Fujimoto…�- The Journal of�…, 2017 - Elsevier
… A total of 71 refractory patients with Kawasaki disease (median age: 2.4 years) of 365 patients
with Kawasaki disease were treated according to our strategy from April 2007 to April 2016…

Kawasaki disease: characteristics, diagnosis, and unusual presentations

AK Jindal, RK Pilania, A Prithvi, S Guleria…�- …�Review of Clinical�…, 2019 - Taylor & Francis
Kawasaki disease (KD) is a small to medium vessel vasculitis that affects infants and young
children [Citation1]. KD predisposes an individual to develop coronary artery aneurysms (…

Diagnosis and management of Kawasaki disease

T Sosa, L Brower, A Divanovic�- JAMA pediatrics, 2019 - jamanetwork.com
… Consider incomplete Kawasaki disease in any child with unexplained fever for at least 7
days or fever for at least 5 days combined with 2 or 3 of the principal clinical features. Infants …

[PDF][PDF] Biomarkers for diagnosis of Kawasaki disease

A Rawat, S Singh�- Indian Pediatr, 2015 - indianpediatrics.net
… The diagnosis of Kawasaki disease is based on a set of clinical criteria, and there is … clinical
presentation of children with Kawasaki disease can be very variable and can test the clinical

Kawasaki disease: a comprehensive review of treatment options

RM Patel, ST Shulman�- …�of Clinical Pharmacy and Therapeutics, 2015 - Wiley Online Library
… criteria can be diagnosed with Kawasaki disease when coronary artery abnormalities are …
, Kawasaki disease diagnosis can be made on day 4 of illness. Experienced clinicians who …

Clinical utility of left atrial strain in children in the acute phase of Kawasaki disease

SJ Kang, YW Kwon, SJ Hwang, HJ Kim, BK Jin…�- Journal of the American�…, 2018 - Elsevier
… Therefore, we evaluated the diagnostic utility of PALS in aKD both before and after, … the
clinical utility of PALS in differentiating aKD from controls. We also aimed to compare the utility of …

Clinical utility of highly purified 10% liquid intravenous immunoglobulin in Kawasaki disease

T Oda, H Nagata, Y Nakashima, E Nanishi…�- The Journal of�…, 2019 - Elsevier
… of highly concentrated IVIG in patients with Kawasaki disease. We hypothesize that shorter-…
management of Kawasaki disease in practice, this study aims to assess the clinical use of a …

Diagnosis of Kawasaki disease

S Singh, AK Jindal, RK Pilania�- …�journal of rheumatic diseases, 2018 - Wiley Online Library
Kawasaki disease in infants is always a diagnostic challenge as infants often may not
manifest the complete form of disease (incomplete KD).27 Incomplete forms of KD should not be …

[HTML][HTML] Controversies in diagnosis and management of Kawasaki disease

RK Pilania, D Bhattarai, S Singh�- World journal of clinical�…, 2018 - ncbi.nlm.nih.gov
… of criteria that are entirely clinical. To further complicate matters, … disease. It is known that
children with incomplete and atypical Kawasaki disease do not have milder form of the disease, …